Azenta (NASDAQ:AZTA) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Azenta (NASDAQ:AZTA) in a research report sent to investors on Monday morning, Benzinga reports. They currently have a $75.00 price objective on the stock.

A number of other analysts also recently commented on the stock. Evercore ISI decreased their price objective on shares of Azenta from $64.00 to $60.00 and set an in-line rating on the stock in a report on Thursday, April 4th. Stephens reissued an equal weight rating and set a $70.00 price objective on shares of Azenta in a report on Thursday, February 8th. B. Riley boosted their price objective on shares of Azenta from $61.00 to $79.00 and gave the stock a buy rating in a report on Thursday, February 1st. Finally, Jefferies Financial Group began coverage on shares of Azenta in a report on Thursday, April 4th. They set a hold rating and a $64.00 price objective on the stock. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of Hold and an average price target of $69.60.

Azenta Stock Down 1.3 %

Shares of NASDAQ:AZTA opened at $56.72 on Monday. The company has a market cap of $3.16 billion, a price-to-earnings ratio of -182.96 and a beta of 1.53. The firm’s 50-day simple moving average is $62.84 and its 200-day simple moving average is $58.75. Azenta has a fifty-two week low of $36.01 and a fifty-two week high of $69.16.

Azenta (NASDAQ:AZTA) last issued its earnings results on Wednesday, February 7th. The company reported $0.02 earnings per share for the quarter. The business had revenue of $154.32 million for the quarter, compared to the consensus estimate of $151.86 million. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. On average, research analysts forecast that Azenta will post 0.27 EPS for the current year.

Institutional Investors Weigh In On Azenta

Large investors have recently bought and sold shares of the stock. TFC Financial Management Inc. purchased a new stake in shares of Azenta in the third quarter valued at $25,000. Headlands Technologies LLC acquired a new position in Azenta in the 3rd quarter valued at about $33,000. Principal Securities Inc. purchased a new position in Azenta in the 4th quarter valued at about $36,000. Northwest Financial Advisors acquired a new stake in shares of Azenta during the 4th quarter worth about $46,000. Finally, Point72 Europe London LLP purchased a new stake in shares of Azenta during the fourth quarter worth about $48,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.